| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/19/2009 | EP2089002A1 Phenylalkyl carbamate compositions |
| 08/19/2009 | EP2089000A2 Injectable depot composition and its process of preparation |
| 08/19/2009 | EP2088996A1 Liquid pharmaceutical compositions comprising a bisphosphonate compound |
| 08/19/2009 | EP1753431B1 Pharmaceutical compositions comprising zd6474 |
| 08/19/2009 | EP1696923B1 Nicotine delivery product and method for producing |
| 08/19/2009 | EP1644045B1 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell |
| 08/19/2009 | EP1556006A4 Water soluble sheet composition |
| 08/19/2009 | EP1480653B1 Ribavirin syrup formulations |
| 08/19/2009 | EP1478339B9 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 08/19/2009 | EP1465593B1 Solid orally-dispersible pharmaceutical formulation |
| 08/19/2009 | EP1463529B1 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 08/19/2009 | EP1420743B1 Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function |
| 08/19/2009 | EP1339425B1 Vaccine composition containing transforming growth factor alpha |
| 08/19/2009 | EP1280566B1 Growth factor modified protein matrices for tissue engineering |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis |
| 08/19/2009 | EP0971740B1 Fibronectin binding protein derived peptides which do not bind to fibronectin, antibodies thereto, and therapeutic uses |
| 08/19/2009 | CN101511875A Thiolated macromolecules and methods of making and using thereof |
| 08/19/2009 | CN101511430A Antibiotic composition |
| 08/19/2009 | CN101511392A Nanogel contrast agents for optical molecular imaging |
| 08/19/2009 | CN101511391A N-terminal derivatisation of proteins with polysaccharides |
| 08/19/2009 | CN101511390A Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol) |
| 08/19/2009 | CN101511389A Targeted imaging and/or therapy using the [3+2] azide-alkyne cycloaddition |
| 08/19/2009 | CN101511388A Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 08/19/2009 | CN101511371A Adhesive preparation |
| 08/19/2009 | CN101511370A Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability |
| 08/19/2009 | CN101511367A Prostaglandin fat emulsion, method for producing the same, method for stabilizing the same, and emulsifying agent |
| 08/19/2009 | CN101511362A Aqueous formulation comprising an antitumor agent |
| 08/19/2009 | CN101511348A Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 08/19/2009 | CN101511346A Programmable buoyant delivery technology |
| 08/19/2009 | CN101511343A Use of polyols to obtain stable polymorphous forms of rifaximin |
| 08/19/2009 | CN101511342A Dry powder compound formulations and uses thereof |
| 08/19/2009 | CN101509011A Carrier containing immunoglobulinlg gene, construction method and uses thereof |
| 08/19/2009 | CN101508993A Bullfrog lectin gene, encoded lectin and uses thereof |
| 08/19/2009 | CN101508970A Immune cell modification method and cell modification device |
| 08/19/2009 | CN101508707A Production process for medicinal sucrose |
| 08/19/2009 | CN101508429A Hydroxyapatite nano-complex particle, preparation and uses thereof |
| 08/19/2009 | CN101507833A Injectable in-situ gel preparation method using poly aspartic acid derivate |
| 08/19/2009 | CN101507821A Medicine for treating malignant cerebroma and breast cancer by combining gene and chemotherapy medicine and preparation method thereof |
| 08/19/2009 | CN101507820A Manufacture of polyglutamate-therapeutic agent conjugates |
| 08/19/2009 | CN101507819A Large-grainsize medicine intercalated hydrotalcite and preparation method thereof |
| 08/19/2009 | CN101507818A Capsaicin beta-cyclodectrin inclusion-compound and liposome and gel of inclusion-compound |
| 08/19/2009 | CN101507817A High-safety polysorbate-80 for injection and preparation method thereof |
| 08/19/2009 | CN101507815A Vibrio harveyi recombined outer-membrane protein Ompk microspheres vaccine and preparation method thereof |
| 08/19/2009 | CN101507812A Aluminum adjuvant dry-power vaccine and preparation method thereof |
| 08/19/2009 | CN101507788A Medicine combination of oxymatrine and chinaroot greenbrier extract and use thereof |
| 08/19/2009 | CN101507752A Prunella vulgaris extract dispersible tablets and preparation method and use thereof |
| 08/19/2009 | CN101507747A Preparation method of astragalus total-saponin sodium chloride injector |
| 08/19/2009 | CN101507741A Red beet extract and composite and preparation method and use thereof in preparing medicine for restraining tumor growth |
| 08/19/2009 | CN101507738A Preparation method of Shu Xuening injection |
| 08/19/2009 | CN101507731A Chitosan uterus-neck antibiotic film and preparation method thereof |
| 08/19/2009 | CN101507723A Combination medicine capable of treating pneumonia and upper respiratory tract infection and preparation method thereof |
| 08/19/2009 | CN101507718A Sodium rabeprazole enteric-coated orally disintegrating tablets and preparation method thereof |
| 08/19/2009 | CN101507717A Composite tablet capable of treating peptic ulcer and preparation method thereof |
| 08/19/2009 | CN101507715A Solid preparation of angiotensin receptor inhibitor and amlodipine and new preparation method thereof |
| 08/19/2009 | CN101507713A High bioavailability proton pump inhibitor sustained-release technique |
| 08/19/2009 | CN101507712A Sustained-release micro-spheres preparation containing recombined erythropoietin and preparation method and use thereof |
| 08/19/2009 | CN101507711A Ligustrazine micro-spheres and preparation method thereof |
| 08/19/2009 | CN101507710A Safe selenium-complement sustained-release microspheres and preparation method thereof |
| 08/19/2009 | CN101507709A Interleukin -2 liposome and preparation method thereof |
| 08/19/2009 | CN101507708A Preparation method of liposome |
| 08/19/2009 | CN101507707A Fasudil hydrochloride lipo-microballoons carrier preparation and preparation method thereof |
| 08/19/2009 | CN101507706A Biodegradable in-situ solidification sustained-release injector |
| 08/19/2009 | CN101507705A Preparation method of block polymer micelle administration system with targeting effect |
| 08/19/2009 | CN101507704A Lutein solid dispersoid and preparation method thereof |
| 08/19/2009 | CN100528956C Nano particle of enwrapping water-soluble active ingredient, and preparation method |
| 08/19/2009 | CN100528325C Preparation method for loading functional in organic micromolecules |
| 08/19/2009 | CN100528241C Vitamin-targeted imaging agents |
| 08/19/2009 | CN100528237C Preparation of polynuclear iron hydroxide-sugar composite |
| 08/19/2009 | CN100528236C Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and beta-cyclodextrin by microwave treatment |
| 08/19/2009 | CN100528235C Conjugates of erythropoietin |
| 08/19/2009 | CN100528234C Lactobionic acid azithromycin for injections and preparation method thereof |
| 08/19/2009 | CN100528233C Process for producing coated preparation having relieved unpleasantness |
| 08/19/2009 | CN100528232C Pharmaceutical preparation in form of suspension comprising acid-labile active ingredient |
| 08/19/2009 | CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/19/2009 | CN100528203C Dragon's blood dropping pill and its preparing process |
| 08/19/2009 | CN100528199C Traditional Chinese medicine compound for expelling tritium |
| 08/19/2009 | CN100528174C Combination of cytidine disodium triphosphate and arginine, and preparation method thereof |
| 08/19/2009 | CN100528162C Pharmaceutical compositions |
| 08/19/2009 | CN100528161C Medicinal composition |
| 08/19/2009 | CN100528160C An antibacterial rifampicin nanoemulsion and preparation method thereof |
| 08/19/2009 | CN100528157C Form of presentation for 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] propionic acid ethyl ester to be administered oral |
| 08/19/2009 | CN100528155C Nanometer berberine hydrochloride emulsion and its preparation process |
| 08/19/2009 | CN100528153C Percutaneous absorption type cerebral protective agent |
| 08/19/2009 | CN100528148C Oil-in-water type nanometer peonol emulsion oral liquid and its preparation process |
| 08/19/2009 | CN100528143C Method of preparing concentrated pill of six ingredients with rehmannia |
| 08/18/2009 | US7576255 Silver-containing compositions, devices, and methods for making |
| 08/18/2009 | US7576193 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 08/18/2009 | US7576186 Composition of matter for delivering and/or affixing a stem cell to a target tissue comprising a first moiety that specifically binds to the stem cell surface operably affixed to a second moiety that specifically binds to the surface of a cell in the tissue |
| 08/18/2009 | US7576067 Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption |
| 08/18/2009 | US7576059 Peptide derivatives |
| 08/18/2009 | US7576058 Method for importing biologically active molecules into cells |
| 08/18/2009 | US7576056 Peptides and compounds that bind to a receptor |
| 08/18/2009 | US7575904 Polymer grafting by polysaccharide synthases |
| 08/18/2009 | US7575768 Fat-based composition substantially free of exogenous solubilizing and dispersing agents for phytosterols, comprising triglyceride-based edible oil or fat comprising 10% omega-3 fatty acids and one or more non-esterified phytosterols that have been converted to triglyceride-recrystallized phytosterols |
| 08/18/2009 | US7575762 Composition comprises sustained-release fine particles and manufacturing method thereof |
| 08/18/2009 | US7575757 Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof |
| 08/18/2009 | US7575748 Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
| 08/18/2009 | CA2548739C Uv-stable, liquid or semisolid transdermal administration form comprising a photosensitive active ingredient |
| 08/18/2009 | CA2424554C Antacid and laxative tablet |